Financials UMediC Group

Equities

UMC

MYQ0256OO006

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
0.69 ^MYR	-1.43%		-2.82%	-2.13%

10/06	UMediC Group Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
12/03	UMediC Group's Profit Slips in Fiscal Q2; Shares Rise 3%	MT

Valuation

Fiscal Period: Juli	2022	2023	2024	2025	2026
Capitalization ¹	183.2	263.6	258	-	-
Enterprise Value (EV) ¹	187.1	242.8	252.7	248.9	243.4
P/E ratio	28.5 x	25.5 x	27.1 x	20.9 x	15.2 x
Yield	-	-	-	-	-
Capitalization / Revenue	3.61 x	5.8 x	4.8 x	3.93 x	3.11 x
EV / Revenue	3.69 x	5.34 x	4.7 x	3.79 x	2.93 x
EV / EBITDA	16.9 x	15.8 x	17.1 x	13.4 x	9.83 x
EV / FCF	25 x	-69.2 x	57.4 x	38 x	25.6 x
FCF Yield	3.99%	-1.45%	1.74%	2.63%	3.9%
Price to Book	3.48 x	4.18 x	3.59 x	3.08 x	2.54 x
Nbr of stocks (in thousands)	3,73,910	3,73,910	3,73,910	-	-
Reference price ²	0.4900	0.7050	0.6900	0.6900	0.6900
Announcement Date	13/09/22	12/09/23	-	-	-

¹MYR in Million²MYR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July	2021	2022	2023	2024	2025	2026
Net sales ¹	-	50.74	45.43	53.8	65.65	82.95
EBITDA ¹	-	11.04	15.37	14.75	18.55	24.75
EBIT ¹	-	9.289	13.18	12.5	16.2	24.7
Operating Margin	-	18.31%	29.02%	23.23%	24.68%	29.78%
Earnings before Tax (EBT) ¹	-	8.482	12.93	12.65	16.6	22.9
Net income ¹	5.087	6.426	10.32	9.5	12.4	17.1
Net margin	-	12.67%	22.71%	17.66%	18.89%	20.61%
EPS ²	0.0136	0.0172	0.0276	0.0255	0.0330	0.0455
Free Cash Flow ¹	-	7.468	-3.509	4.4	6.55	9.5
FCF margin	-	14.72%	-7.72%	8.18%	9.98%	11.45%
FCF Conversion (EBITDA)	-	67.67%	-	29.83%	35.31%	38.38%
FCF Conversion (Net income)	-	116.22%	-	46.32%	52.82%	55.56%
Dividend per Share	-	-	-	-	-	-
Announcement Date	07/12/21	13/09/22	12/09/23	-	-	-

¹MYR in Million²MYR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: July	2023 Q3	2023 Q4
Net sales	-	-
EBITDA	-	-
EBIT	-	-
Operating Margin	-	-
Earnings before Tax (EBT)	-	-
Net income ¹	2.035	3.371
Net margin	-	-
EPS	0.005400	-
Dividend per Share	-	-
Announcement Date	07/06/23	12/09/23

¹MYR in Million

Estimates

Balance Sheet Analysis

Fiscal Period: July	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	3.84	-	-	-	-
Net Cash position ¹	-	-	20.8	5.3	9.1	14.6
Leverage (Debt/EBITDA)	-	0.3476 x	-	-	-	-
Free Cash Flow ¹	-	7.47	-3.51	4.4	6.55	9.5
ROE (net income / shareholders' equity)	-	18.8%	17.8%	13.8%	14%	17.7%
ROA (Net income/ Total Assets)	-	10.8%	14.5%	-	-	-
Assets ¹	-	59.41	71.11	-	-	-
Book Value Per Share ²	-	0.1400	0.1700	0.1900	0.2200	0.2700
Cash Flow per Share	-	-	-	-	-	-
Capex ¹	-	1.01	5.31	3	3	3
Capex / Sales	-	1.99%	11.69%	5.58%	4.57%	3.62%
Announcement Date	07/12/21	13/09/22	12/09/23	-	-	-

¹MYR in Million²MYR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for UMediC Group

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.69 MYR

Average target price

0.95 MYR

Spread / Average Target

+37.68%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
UMEDIC GROUP	-2.13%	54.76M
ABBOTT LABORATORIES	-4.33%	183B
MEDTRONIC PLC	-1.63%	104B
BECTON, DICKINSON AND COMPANY	-3.25%	68.18B
CENCORA, INC.	+16.54%	47.14B
DEXCOM, INC.	-10.90%	43.97B
HOYA CORPORATION	+6.70%	40.95B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.87%	31.05B
WEST PHARMACEUTICAL SERVICES, INC.	-6.00%	24.11B
TERUMO CORPORATION	+12.48%	24.05B

Other Medical Equipment, Supplies & Distribution